Looking for and Quantifying Value in Rare Diseases: 6th November, 2018

groupH was selected to present on the topic of Looking for and Quantifying Value in Rare Diseases at an EphMRA meeting in Basel on 6th November, 2018.

Rare diseases present a number of challenges for manufacturers, which are absent in more prevalent conditions.  So which approach should you take when trying to determine value?

In his presentation Erik Holzinger addresses this question and highlights some of the issues involved.

Click here to view this presentation.

New Directions in Forecasting – Roundtable at EphMRA 2018 in Basel, 27 June

The role of forecasting as a business function, or if used as a tool in and outside of Pharma / Device organisations, continues to evolve at a fast pace.  Ben Collins (Boehringer Ingelheim) and Erik Holzinger (groupH) are hosting a round-table discussion during this year’s annual EphMRA 2018 Conference in Basel, to open up a number of key topics to a wider audience, share views and develop a consensus as to which approach suits which business situation and leads to best possible outcomes.

1.    Organising the forecasting process across the Pharma organisation

  • Best Practice – How do central office and affiliates communicate and create consensus on assumptions?
  • What is the general process – Can vendors help? How?

2.    How to communicate strategic forecasts and illustrate uncertainties to senior management (does Monte Carlo simulation have a role here? If yes, how do you use it?)
3.    Early insights into the application of Behavioural Economics to the forecasting process
4.    Best Practice – Required granularity and scope in forecasting strategic pipeline and in-licensing assets: US + RoW?

The conference also includes a number of papers on related topics covering different case studies on the use of collaborative software for forecasting within multi-national organisations and novel approaches to data analytics in auto-immune diseases using Electronic Medical Records to augment traditional primary research.

Please join them to rub shoulders with leading experts in the industry, get inspired by the use of novel ground-breaking technologies and join the discussion on the current state and future direction of this important business function.

Click www.ephmraconference.org for conference website and registration, click www.ephmraconference.org/home/programme for the full conference programme.

If this is of interest please let us know, and we will ensure you have a place at the table.

Meet us in San Francisco at Biotech Showcase: 8-10 January 2018

As we’re sure you are aware, the biggest healthcare investing event of the year, the JP Morgan Healthcare Conference, will be returning to San Francisco in early January.

groupH will be attending the Biotech Showcase – navigating the packed agenda of company presentations, panel discussions, and networking receptions.

If you’re in San Francisco for these events, we’d love to meet up to discuss your latest commercializing plans, the potential impact of changes to the competitor landscape, and incorporating the needs of physicians, payers, and patients into your strategic planning.

We look forward to meeting informally over a coffee or through the meeting partnering platform.

Join groupH in Amsterdam at EphMRA: 20-22 June, 2017

Join groupH at EphMRA 2017 in Amsterdam between 20-22 June. Erik Holzinger will be chairing several sessions and also co-presenting with Bernd Mühlenweg from Nanobiotix. Their session will explore the benefits of addressing the payer hurdle very early in clinical development, and will focus on sharing ideas and best practice.

“How engaging payers early transformed our clinical development and portfolio planning – a case study” will be presented on Wednesday 21 June at 2.45pm.

If you or your colleagues are also attending EphMRA 2017, we would be very happy to meet up. Please drop us a line to arrange this.

Even if you can’t make it, we would be happy to share our perspectives from the conference, so do get in touch if you are interested in learning more about the topics that are discussed or about groupH’s work

groupH at World Orphan Drug Congress, Brussels, 15 – 17 November, 2016

Join Erik Holzinger in Brussels. We would be very happy to meet up or to share our perspectives from the conference in case you are not attending this event.